Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma

Ikeda Kenji; Kawamura Yusuke; Kobayashi Masahiro; Kominami Yoko; Fujiyama Shunichiro; Sezaki Hitomi; Hosaka Tetsuya; Akuta Norio; Saitoh Satoshi; Suzuki Fumitaka; Suzuki Yoshiyuki; Arase Yasuji; Kumada Hiromitsu

首页> 外文期刊>Digestive Diseases and Sciences >Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma

【24h】

Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma

机译：直接作用抗病毒在丙型肝炎病毒相关肝细胞癌初始治疗后降低肿瘤复发

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background Suppressive activity of recurrence by interferon- free direct-acting antivirals (DAA) is not elucidated after curative treatment of hepatocellular carcinoma (HCC).

机译：背景技术在肝细胞癌（HCC）的治疗后，不阐明通过干扰素直接抗病毒（DAA）复发的抑制活性。

著录项

来源
《Digestive Diseases and Sciences》 |2017年第10期|共11页
作者
Ikeda Kenji; Kawamura Yusuke; Kobayashi Masahiro; Kominami Yoko; Fujiyama Shunichiro; Sezaki Hitomi; Hosaka Tetsuya; Akuta Norio; Saitoh Satoshi; Suzuki Fumitaka; Suzuki Yoshiyuki; Arase Yasuji; Kumada Hiromitsu;
展开▼
作者单位

Toranomon Gen Hosp Dept Hepatol Minato Ku Toranomon 2-2-2 Tokyo 1058470 Japan;

Toranomon Gen Hosp Dept Hepatol Minato Ku Toranomon 2-2-2 Tokyo 1058470 Japan;

Toranomon Gen Hosp Dept Hepatol Minato Ku Toranomon 2-2-2 Tokyo 1058470 Japan;

Toranomon Gen Hosp Dept Hepatol Minato Ku Toranomon 2-2-2 Tokyo 1058470 Japan;

Toranomon Gen Hosp Dept Hepatol Minato Ku Toranomon 2-2-2 Tokyo 1058470 Japan;

Toranomon Gen Hosp Dept Hepatol Minato Ku Toranomon 2-2-2 Tokyo 1058470 Japan;

Toranomon Gen Hosp Dept Hepatol Minato Ku Toranomon 2-2-2 Tokyo 1058470 Japan;

Toranomon Gen Hosp Dept Hepatol Minato Ku Toranomon 2-2-2 Tokyo 1058470 Japan;

Toranomon Gen Hosp Dept Hepatol Minato Ku Toranomon 2-2-2 Tokyo 1058470 Japan;

Toranomon Gen Hosp Dept Hepatol Minato Ku Toranomon 2-2-2 Tokyo 1058470 Japan;

Toranomon Gen Hosp Dept Hepatol Minato Ku Toranomon 2-2-2 Tokyo 1058470 Japan;

Toranomon Gen Hosp Dept Hepatol Minato Ku Toranomon 2-2-2 Tokyo 1058470 Japan;

Toranomon Gen Hosp Dept Hepatol Minato Ku Toranomon 2-2-2 Tokyo 1058470 Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
Hepatocellular carcinoma (HCC); Directacting antivirals (DAA); Recurrence; Sustained virological response (SVR); Survival;

机译：肝细胞癌（HCC）;直接抗病毒（DAA）;复发;持续的病毒学反应（SVR）;生存;

相似文献

外文文献
中文文献
专利

1. Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma [J] . Ikeda Kenji, Kawamura Yusuke, Kobayashi Masahiro, Digestive Diseases and Sciences . 2017,第10期

机译：直接作用抗病毒在丙型肝炎病毒相关肝细胞癌初始治疗后降低肿瘤复发
2. Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma [J] . Li Zheng, Lei Zhengqing, Xia Yong, JAMA surgery . 2018,第10期

机译：术前抗病毒治疗与微血管侵袭和早期肿瘤复发发生相关肝炎病毒相关肝细胞癌
3. Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment and antiviral therapy [J] . Tsai Pei-Chien, Huang Chung-Feng, Yu Ming-Lung Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2017,第2期

机译：丙型肝炎病毒相关肝细胞癌患者发生意外的早期肿瘤复发：在无干扰素治疗中：HCC治疗与抗病毒治疗之间的间隔问题
4. Detection of network structure changes by graphical chain modeling: a case study of hepatitis C virus-related hepatocellular carcinoma [C] . Shigeru Saito, Masao Honda, Shu-ichi Kaneko, IEEE Conference on Decision and Control . 2009

机译：图形链模型检测网络结构改变：丙型肝炎病毒相关肝细胞癌的案例研究
5. Healthcare Resources Utilization, Inpatient Mortality, and Risk Behaviors among Patients Infected with Hepatitis C Virus in the United States in the Era of Direct-Acting Antivirals [D] . Alzahrani, Mohammad Saeed. 2020

机译：在直接作用抗病毒中，美国乙型肝炎病毒感染患者的医疗资源利用率，住院死亡率和风险行为
6. Decreased risk of hepatocellular carcinoma recurrence with direct-acting antivirals compared with no treatment for hepatitis C: a meta-analysis [O] . Felix H. Lui, Zain Moosvi, Anish Patel, 2020

机译：与未治疗丙型肝炎相比直接作用抗病毒药物可降低肝细胞癌复发的风险：一项荟萃分析
7. Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment and antiviral therapy [O] . Pei-Chien Tsai, Chung-Feng Huang, Ming-Lung Yu 2017

机译：丙型肝炎病毒相关肝细胞癌患者发生意外的早期肿瘤复发：在无干扰素治疗中：HCC治疗与抗病毒治疗之间的间隔问题

Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅